TCM Ltd
Incorporated in 1943, TCM Ltd manufactures chemicals having and trades solar equipments and healthcare devices[1]
- Market Cap ₹ 47.9 Cr.
- Current Price ₹ 64.1
- High / Low ₹ 81.0 / 35.0
- Stock P/E 320
- Book Value ₹ 36.8
- Dividend Yield 0.00 %
- ROCE 6.32 %
- ROE 6.04 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 141 to 95.0 days.
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -4.76% over last 3 years.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.5.06 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 0.40 | 0.92 | 4.23 | 3.55 | 7.35 | 32.23 | 26.01 | 22.96 | |
| 1.26 | 1.75 | 5.11 | 7.56 | 11.01 | 34.45 | 27.97 | 26.28 | |
| Operating Profit | -0.86 | -0.83 | -0.88 | -4.01 | -3.66 | -2.22 | -1.96 | -3.32 |
| OPM % | -215.00% | -90.22% | -20.80% | -112.96% | -49.80% | -6.89% | -7.54% | -14.46% |
| 0.04 | 1.15 | 1.23 | -1.69 | 0.02 | 0.43 | 4.29 | 5.06 | |
| Interest | 0.12 | 0.01 | 0.01 | 0.01 | 0.28 | 0.16 | 0.61 | 1.48 |
| Depreciation | 0.00 | 0.01 | 0.03 | 0.17 | 0.37 | 0.30 | 0.35 | 0.40 |
| Profit before tax | -0.94 | 0.30 | 0.31 | -5.88 | -4.29 | -2.25 | 1.37 | -0.14 |
| Tax % | 0.00% | 0.00% | 61.29% | 0.00% | -0.70% | 1.78% | -2.19% | |
| -0.95 | 0.30 | 0.12 | -5.88 | -4.27 | -2.29 | 1.40 | -0.05 | |
| EPS in Rs | -1.27 | 0.40 | 0.16 | -6.85 | -5.35 | -2.61 | 2.15 | 0.20 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 95% |
| 3 Years: | 94% |
| TTM: | -28% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 43% |
| 3 Years: | 37% |
| TTM: | 113% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 18% |
| 3 Years: | 11% |
| 1 Year: | 30% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -5% |
| 3 Years: | -5% |
| Last Year: | 6% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.40 | 3.40 | 3.40 | 3.40 | 7.48 | 7.48 | 7.48 | 7.48 |
| Reserves | 29.02 | 29.07 | 29.19 | 21.93 | 23.26 | 21.31 | 23.04 | 20.01 |
| 5.38 | 5.64 | 5.83 | 6.53 | 1.44 | 0.27 | 11.22 | 20.68 | |
| 31.35 | 27.33 | 29.32 | 29.58 | 36.63 | 54.74 | 34.66 | 35.04 | |
| Total Liabilities | 69.15 | 65.44 | 67.74 | 61.44 | 68.81 | 83.80 | 76.40 | 83.21 |
| 58.01 | 58.01 | 58.82 | 55.28 | 35.70 | 17.28 | 14.09 | 14.24 | |
| CWIP | 0.00 | 0.00 | 0.06 | 0.02 | 0.10 | 0.10 | 0.10 | 2.05 |
| Investments | 0.44 | 0.19 | 0.18 | 0.00 | 0.00 | 0.00 | 0.30 | 0.30 |
| 10.70 | 7.24 | 8.68 | 6.14 | 33.01 | 66.42 | 61.91 | 66.62 | |
| Total Assets | 69.15 | 65.44 | 67.74 | 61.44 | 68.81 | 83.80 | 76.40 | 83.21 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| -1.63 | -0.57 | 0.39 | -4.21 | -10.87 | 1.95 | -10.08 | |
| 0.01 | 0.00 | -0.51 | 4.22 | 5.84 | -0.64 | -0.18 | |
| 5.32 | -3.14 | 0.18 | 0.19 | 4.87 | -1.30 | 10.37 | |
| Net Cash Flow | 3.69 | -3.70 | 0.06 | 0.20 | -0.15 | 0.00 | 0.11 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 1,377.88 | 706.20 | 217.45 | 195.35 | 232.90 | 96.37 | 95.00 |
| Inventory Days | 1,477.38 | 847.92 | 467.90 | 192.33 | 269.66 | 852.04 | 570.68 |
| Days Payable | 2,581.07 | 1,914.85 | 743.59 | 77.21 | 91.07 | 78.85 | 50.16 |
| Cash Conversion Cycle | 274.18 | -360.73 | -58.24 | 310.47 | 411.49 | 869.56 | 615.52 |
| Working Capital Days | -10,986.50 | -3,261.20 | -818.01 | -1,356.15 | -487.66 | 98.19 | -74.23 |
| ROCE % | 0.82% | -0.16% | -10.58% | -12.90% | -7.04% | 6.32% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 13 Nov
-
Board Meeting Outcome for And The Consolidated And Standalone Unaudited Financial Results Along With The Consolidated And Standalone Limited Review Reports For The Quarter Ended 30Th September 2025
11 Nov - Unaudited Q2 results for quarter ended 30 Sep 2025; proposed Better Feeds acquisition ₹765 lakh; ₹102.56 lakh advance paid.
-
Intimation Under Regulation 30 Of The SEBI(LODR) Regulations 2015 For Opening Of The Healthcare Division Office Of The Company
10 Nov - Opened Healthcare Division office in Maradu, Ernakulam; 1,621 sq ft; 10 Nov 2025.
-
Board Meeting Intimation for Consideration And Approval Of The Consolidated And Standalone Unaudited Financial Results For The Quarter Ended 30Th September 2025
29 Oct - Board meeting 11 Nov 2025 to approve Q2 (30 Sep 2025) unaudited financial results; trading window remains closed.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
14 Oct - Confirmation Certificate under Regulation 74(5) of SEBI(Depositories and Participants) Regulations, 2018 for the quarter ending 30th September 2025 received from our RTA, M/s Cameo Corporate …
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview:[1]
Company trading of medical products,
GPS-enabled Automatic Headlight Beam Assist System for vehicles under the brand name of ENSO, and the business of setting up and commissioning Solar Power plants